Medicaroid secures CE marking for hinotori™ surgical robot system
Med-Tech Insights reports that Medicaroid has achieved CE marking under the Medical Device Regulation (MDR) for its hinotori™ Surgical Robot System, allowing the platform to be marketed across EU member states and selected non-EU countries. The milestone marks a significant step in the company's global expansion, following successful commercialisation in Japan and regulatory approvals across several Asia-Pacific markets.
The European approval reflects the continued growth of robotic-assisted surgery and the increasing adoption of advanced surgical technologies designed to improve precision, support minimally invasive procedures and enhance patient outcomes. As more healthcare providers invest in robotic platforms, innovations like the hinotori™ system are expected to play an important role in shaping the future of surgery across Europe and beyond.
🔗 Read the full article on Med-Tech Insights: Medicaroid obtains CE marking for hinotori™ Surgical Robot System
Credit for images and content: Med-Tech Insights
____________________________________________________________________________________________________________________________________________________________________________________________________
Cure Talent is a recruitment agency dedicated to the medical technology industry. Whether you are looking for a new role in the medical device sector or you’re an innovative medical device, digital health, or biotech company looking for staff, get in touch with the team today and explore how Cure Talent can help!